If you scan the landscape of colorectal cancer screening tests in the US, you will find companies positioning their blood-based screening tests on various perches – some waiting for imminent launches,
Derived from Strategic Transactions , Informa ’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant indu